Growth Metrics

Coherus Oncology (CHRS) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Coherus Oncology (CHRS) over the last 13 years, with Q3 2025 value amounting to $8.7 million.

  • Coherus Oncology's Prepaid Assets fell 3862.87% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year decrease of 3862.87%. This contributed to the annual value of $10.2 million for FY2024, which is 5686.92% down from last year.
  • According to the latest figures from Q3 2025, Coherus Oncology's Prepaid Assets is $8.7 million, which was down 3862.87% from $11.7 million recorded in Q2 2025.
  • Coherus Oncology's Prepaid Assets' 5-year high stood at $23.7 million during Q4 2023, with a 5-year trough of $8.7 million in Q3 2025.
  • For the 5-year period, Coherus Oncology's Prepaid Assets averaged around $16.5 million, with its median value being $15.9 million (2025).
  • Per our database at Business Quant, Coherus Oncology's Prepaid Assets surged by 6728.47% in 2022 and then plummeted by 5686.92% in 2024.
  • Coherus Oncology's Prepaid Assets (Quarter) stood at $13.7 million in 2021, then surged by 67.28% to $22.9 million in 2022, then rose by 3.41% to $23.7 million in 2023, then plummeted by 56.87% to $10.2 million in 2024, then fell by 14.89% to $8.7 million in 2025.
  • Its Prepaid Assets stands at $8.7 million for Q3 2025, versus $11.7 million for Q2 2025 and $15.9 million for Q1 2025.